cSSSI: Complicated skin and skin-structure infection; ESBL: Extended spectrum β lactamase; MRSA: Methicillin-resistant Staphylococcus aureus; MSSA: Methicillin-susceptible Staphylococcus aureus.

MRSA - or methicillin resistant staphylococcus ... This indicates that new strains are spreading which are resistant to traditional treatment. He added: 'If the new community-acquired MRSA clones ...

Without treatment, the infection can enter ... which is the incubation period for the infection. Methicillin-resistant Staphylococcus aureus (MRSA) is a type of staph bacteria highly resistant ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Antibiotic treatment during an influenza infection actually impaired the body’s efforts to clear bacteria rather than helping the body heal.

In April 2024, the U.S. Food and Drug Administration (FDA) approved Zevtera for three specific treatment indications, and it is the only FDA-approved methicillin-resistant Staphylococcus aureus ...

P-128 is under clinical development by GangaGen Biotechnologies and currently in Phase II for Staphylococcus aureus Infections.